Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Details

Autor(en) / Beteiligte
Titel
Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease
Ist Teil von
  • The New England journal of medicine, 2016-03, Vol.374 (13), p.1209-1220
Ort / Verlag
Boston: Massachusetts Medical Society
Erscheinungsjahr
2016
Link zum Volltext
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
  • In this randomized, controlled trial from Europe involving patients with persistent symptoms attributed to Lyme disease, there was no benefit associated with 12 additional weeks of treatment with either doxycycline or clarithromycin–hydroxychloroquine. Patients with Lyme disease, which is caused by the Borrelia burgdorferi sensu lato complex (including B. afzelii and B. garinii in Europe), often report persistent symptoms. 1 These symptoms are also referred to as the post–Lyme disease syndrome or chronic Lyme disease and may occur after resolution of an erythema migrans rash or after other — possibly unnoticed — manifestations of early Lyme disease, regardless of whether a patient received initial appropriate antibiotic treatment. Patients present mainly with pain, fatigue, and neurologic or cognitive disturbances. 2 , 3 Previous randomized, clinical trials have not shown convincingly that prolonged antibiotic treatment has beneficial effects . . .

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX